Mounjaro®
Starting from £179.99/mo
Start journey Learn moreAfter you inject Wegovy, the pen should click, the plunger should bottom out, and you'll usually feel nothing more than mild pressure at the site. Most people notice a small amount of clear or faintly yellow liquid has left the pen — that's your clearest confirmation it went in. Here's what the guidance and clinical experience tell us about reading the signs correctly.
Wegovy (semaglutide) is a prescription-only medicine; every dose change and technique question is worth raising with your prescriber. The NHS semaglutide page has a short summary of injection technique, and the full Patient Information Leaflet that comes with your pens is the authoritative step-by-step reference.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The strongest evidence that a Wegovy dose delivered correctly comes from the device, not from how your body feels. The Wegovy FlexTouch pen has a clear inspection window. Before you inject, the liquid is visible. After a successful injection (needle held in place for at least six seconds with the plunger fully pressed) that window should be empty, or nearly so. A very small residual droplet is normal manufacturing tolerance; the therapeutic volume has still been delivered.
The click you hear when the plunger reaches the end of its travel is the mechanism locking, not the injection completing. Hold the pen pressed against your skin for a full six seconds after that click before withdrawing. Pulling out early is the most common reason people suspect a missed dose. The practical things to know about Wegovy covers this in more detail, including the needle-change routine and site rotation.
A locked plunger that will not depress at all usually means the pen has frozen, not a technique error. If your pen ever feels unusually resistant, check our guide on how to tell if Wegovy has frozen before assuming the dose was wasted.
A question our prescribers hear most weeks is whether a small bleed at the site means the medicine came out rather than going in. It doesn't. Subcutaneous tissue has capillaries; nicking one produces a drop of blood but the semaglutide has already dispersed into the fat layer. Likewise, a tiny wet spot on your skin after withdrawal is almost always fluid that sat in the needle shaft, not the medicine itself.
Mild redness, a small raised bump, or slight tenderness around the injection point are all normal and typically resolve within an hour. These reactions reflect your immune system noticing the needle, not a failed injection. What you should not see is a hard lump that persists for days or a large welt, those are worth mentioning at your next clinical review, though they rarely indicate the dose was lost.
Rotating sites (abdomen, thigh, upper arm) matters partly because repeated injection into the same spot causes a local tissue change (lipohypertrophy) that can genuinely reduce absorption. The NHS guidance on semaglutide includes the recommended rotation pattern, and your Patient Information Leaflet illustrates the three approved areas with diagrams.
Many people assume they'll feel something (queasiness, reduced appetite, maybe a headache) within an hour of injecting, and take the absence of symptoms as proof the shot failed. This is understandable but not accurate. Semaglutide's half-life is approximately one week; it accumulates gradually. At early doses (0.25mg and 0.5mg) many people feel nothing at all for days. Even at the 2.4mg maintenance dose, some people on that week's shot experience their main GI effects 24–48 hours later, not immediately.
The reverse is also true: if you've been on Wegovy for several weeks, the medicine already in your system will keep working regardless of one individual shot. A week where you don't notice appetite suppression may reflect diet, sleep or stress more than injection technique, and if digestive changes like wegovy smelly farts have caught you off guard, our dedicated page explains why that happens and what you can do about it. For a fuller picture of what genuine treatment response looks like over time, the guide on how to know Wegovy is working is worth reading alongside this one. And if you're ever certain a shot genuinely went wrong, there's specific guidance on what to do when you don't think your Wegovy shot went in.
Wegovy is a prescription-only medicine. The clinical picture (your weight trend, your side-effect pattern, your dosing history) is what your prescriber uses to judge whether treatment is on track. If you're still weighing up whether this treatment is right for you, our overview of the Wegovy slimming jab sets out how it works, who it suits, and what to expect before you start. If you'd like that clinical conversation without a long wait, you can speak to our prescribers through a free consultation at nume. Sorry, at nume.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.